This country profile provides an overview of South Africa’s progress in reaching those in need of mass NTD treatment based on 2019 data.
*This includes all countries in Africa that are endemic for at least one of the five NTDs
Treatment coverage
Elephantiasis
N/A
Blinding trachoma
N/A
Intestinal worms
14%
Bilharzia
0%
River blindness
N/A
2.25 million
people received treatment in South Africa in 2019
16.56 million
people did not receive treatment in South Africa in 2019
Elephantiasis
South Africa does not require mass treatment for elephantiasis.
Blinding trachoma
South Africa does not require mass treatment for blinding trachoma.
Intestinal worms
Treatment coverage decreased 54% in 2018 to 14% in 2019.
Pre-sch and school-aged children needing treatment
15.83m
Pre-school and school-aged children receiving treatment
2.25m
Bilharzia
Treatment coverage remained at 0% in 2018 and 2019.
School-aged children needing treatment
2.62m
School-aged children receiving treatment
Zero
River blindness
South Africa does not require mass treatment for river blindness.
The 
ESPEN portal (a World Health Organization AFRO region project) provides maps and district-level data for the preventive chemotherapy diseases in South Africa.